Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthes Zessin

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Continuous Histone Deacylase Activity AssaysMatthes Zessin, Marat Meleshin, Wolfgang Sippl, et al.
ACS Chemical Biology|May 31, 2022
Uncovering Robust Delactoylase and Depyruvoylase Activities of HDAC IsoformsMatthes Zessin, Marat Meleshin, Lucas Praetorius, et al.
International Journal of Molecular Sciences|April 28, 2023
Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated LysinesMatthes Zessin, Marat Meleshin, Sebastian Hilscher, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer CompoundsEmre F Bülbül, Dina Robaa, Ping Sun, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Development of Pyrazine-Anilinobenzamides as Histone Deacetylase HDAC1-3 Selective Inhibitors and Biological Testing Against Pancreas Cancer Cell LinesMohamed Abdelsalam, Hany S Ibrahim, Lukas Krauss, et al.
ACS Omega|December 3, 2019
Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC InhibitorsZsófia Kutil, Jana Mikešová, Matthes Zessin, et al.
Journal of Chemical Information and Modeling|April 25, 2022
Development of New Inhibitors of HDAC1-3 Enzymes Aided by <i>In Silico</i> Design StrategiesNarges Cheshmazar, Salar Hemmati, Maryam Hamzeh-Mivehroud, et al.
Molecules (Basel, Switzerland)|April 23, 2022
Docking, Binding Free Energy Calculations and In Vitro Characterization of Pyrazine Linked 2-Aminobenzamides as Novel Class I Histone Deacetylase (HDAC) InhibitorsEmre F Bülbül, Jelena Melesina, Hany S Ibrahim, et al.
Future Medicinal Chemistry|April 16, 2024
Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluationNarges Cheshmazar, Maryam Hamzeh-Mivehroud, Salar Hemmati, et al.
Biochemistry|November 5, 2019
One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase ActivityMatthes Zessin, Zsófia Kutil, Marat Meleshin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Continuous Histone Deacylase Activity AssaysMatthes Zessin, Marat Meleshin, Wolfgang Sippl, et al.
ACS Chemical Biology|May 31, 2022
Uncovering Robust Delactoylase and Depyruvoylase Activities of HDAC IsoformsMatthes Zessin, Marat Meleshin, Lucas Praetorius, et al.
International Journal of Molecular Sciences|April 28, 2023
Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated LysinesMatthes Zessin, Marat Meleshin, Sebastian Hilscher, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer CompoundsEmre F Bülbül, Dina Robaa, Ping Sun, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Development of Pyrazine-Anilinobenzamides as Histone Deacetylase HDAC1-3 Selective Inhibitors and Biological Testing Against Pancreas Cancer Cell LinesMohamed Abdelsalam, Hany S Ibrahim, Lukas Krauss, et al.
ACS Omega|December 3, 2019
Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC InhibitorsZsófia Kutil, Jana Mikešová, Matthes Zessin, et al.
Journal of Chemical Information and Modeling|April 25, 2022
Development of New Inhibitors of HDAC1-3 Enzymes Aided by <i>In Silico</i> Design StrategiesNarges Cheshmazar, Salar Hemmati, Maryam Hamzeh-Mivehroud, et al.
Molecules (Basel, Switzerland)|April 23, 2022
Docking, Binding Free Energy Calculations and In Vitro Characterization of Pyrazine Linked 2-Aminobenzamides as Novel Class I Histone Deacetylase (HDAC) InhibitorsEmre F Bülbül, Jelena Melesina, Hany S Ibrahim, et al.
Future Medicinal Chemistry|April 16, 2024
Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluationNarges Cheshmazar, Maryam Hamzeh-Mivehroud, Salar Hemmati, et al.
Biochemistry|November 5, 2019
One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase ActivityMatthes Zessin, Zsófia Kutil, Marat Meleshin, et al.
Pageof 2